273 related articles for article (PubMed ID: 25890061)
41. Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients.
Wang H; Lan L; Chen J; Xiao L; Han F
Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35973743
[TBL] [Abstract][Full Text] [Related]
42. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
Pradhan VD; Badakere SS; Bichile LS; Almeida AF
J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
[TBL] [Abstract][Full Text] [Related]
43. Expression of inducible co-stimulator on peripheral blood T lymphocytes in patients with lupus nephritis.
Li WX; Pan HF; Chen GP; Tao JH; Li XP; Ye DQ
Rheumatol Int; 2012 Jul; 32(7):2051-5. PubMed ID: 21479882
[TBL] [Abstract][Full Text] [Related]
44. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
[TBL] [Abstract][Full Text] [Related]
45. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis.
Kim J; Jeong JH; Jung J; Jeon H; Lee S; Lim JS; Go H; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Rheumatology (Oxford); 2020 Aug; 59(8):2135-2145. PubMed ID: 32163584
[TBL] [Abstract][Full Text] [Related]
46. Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
Stanley S; Mok CC; Vanarsa K; Habazi D; Li J; Pedroza C; Saxena R; Mohan C
Arthritis Rheumatol; 2019 May; 71(5):744-755. PubMed ID: 30618193
[TBL] [Abstract][Full Text] [Related]
47. Immunoglobulin Binding Protein 1 as a Potential Urine Biomarker in Patients with Lupus Nephritis.
Lee EJ; Kwon OC; Ghang B; Lim DH; Kim DH; Hong S; Lee CK; Yoo B; Kim YG
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137925
[TBL] [Abstract][Full Text] [Related]
48. Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
de Souza AW; Abdulahad WH; Sosicka P; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
Clin Exp Immunol; 2014 Nov; 178(2):270-8. PubMed ID: 25052363
[TBL] [Abstract][Full Text] [Related]
49. Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis.
Jourde-Chiche N; Whalen E; Gondouin B; Speake C; Gersuk V; Dussol B; Burtey S; Pascual V; Chaussabel D; Chiche L
Rheumatology (Oxford); 2017 Mar; 56(3):477-487. PubMed ID: 28031441
[TBL] [Abstract][Full Text] [Related]
50. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis.
Suzuki M; Wiers K; Brooks EB; Greis KD; Haines K; Klein-Gitelman MS; Olson J; Onel K; O'Neil KM; Silverman ED; Tucker L; Ying J; Devarajan P; Brunner HI
Pediatr Res; 2009 May; 65(5):530-6. PubMed ID: 19218887
[TBL] [Abstract][Full Text] [Related]
51. [Distribution of interleukin-6 receptors (CD(126) and CD(w130)) on circulating lymphocytes in patients with lupus nephritis].
Zeng L; Sun L; Ye R; Xu H; Yu X; Kong Q; Zhou F
Zhonghua Nei Ke Za Zhi; 2000 Sep; 39(9):603-6. PubMed ID: 11798527
[TBL] [Abstract][Full Text] [Related]
52. Urinary neutrophil gelatinase-associated lipocalin for diagnosis and estimating activity in lupus nephritis: a meta-analysis.
Fang YG; Chen NN; Cheng YB; Sun SJ; Li HX; Sun F; Xiang Y
Lupus; 2015 Dec; 24(14):1529-39. PubMed ID: 26314302
[TBL] [Abstract][Full Text] [Related]
53. Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis.
Gatto M; Wiedemann A; Nomovi N; Reiter K; Schrezenmeier E; Rose T; Szelinski F; Lino AC; Valentino S; Ghirardello A; Dörner T; Doria A
Front Immunol; 2019; 10():29. PubMed ID: 30740098
[No Abstract] [Full Text] [Related]
54. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children.
Hammad A; Mosaad Y; Elhanbly S; Youssef H; El Refaaey A; Elhusseini F; Bakr A
Lupus; 2013 Apr; 22(5):486-91. PubMed ID: 23554037
[TBL] [Abstract][Full Text] [Related]
55. BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis.
Chalmers SA; Garcia SJ; Webb D; Herlitz L; Fine J; Klein E; Ramanujam M; Putterman C
Clin Immunol; 2021 Feb; 223():108640. PubMed ID: 33296718
[TBL] [Abstract][Full Text] [Related]
56. Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis.
Edelbauer M; Kshirsagar S; Riedl M; Billing H; Tönshoff B; Haffner D; Cortina G; Amon O; Ross S; Dötsch J; Wechselberger G; Weber LT; Dablander M; Anliker M; Griesmacher A; Steichen-Gersdorf E
J Clin Immunol; 2012 Jun; 32(3):477-87. PubMed ID: 22228566
[TBL] [Abstract][Full Text] [Related]
57. The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
Liu L; Wang R; Ding H; Tian L; Gao T; Bao C
PLoS One; 2020; 15(10):e0240942. PubMed ID: 33108403
[TBL] [Abstract][Full Text] [Related]
58. Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis.
Abdulahad WH; Kallenberg CG; Limburg PC; Stegeman CA
Arthritis Rheum; 2009 Sep; 60(9):2830-8. PubMed ID: 19714581
[TBL] [Abstract][Full Text] [Related]
59. HMGB1
Burbano C; Gómez-Puerta JA; Muñoz-Vahos C; Vanegas-García A; Rojas M; Vásquez G; Castaño D
Eur J Immunol; 2019 Feb; 49(2):323-335. PubMed ID: 30537116
[TBL] [Abstract][Full Text] [Related]
60. Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.
Morell M; Pérez-Cózar F; Marañón C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
